Cargando…

Targeting of non-oncogene addiction

Detalles Bibliográficos
Autores principales:	Igea, Ana, Gupta, Jalaj, Nebreda, Angel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586095/ https://www.ncbi.nlm.nih.gov/pubmed/26298432

Ejemplares similares

Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer
por: Gupta, Jalaj, et al.
Publicado: (2015)

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors
por: Gupta, Jalaj, et al.
Publicado: (2015)

Oncogene addiction: resetting the safety switch?
por: Li, Yulin, et al.
Publicado: (2014)

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

Targeting Non-Oncogene Addiction for Cancer Therapy
por: Chang, Hae Ryung, et al.
Publicado: (2021)

Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
por: Anania, Maria Chiara, et al.
Publicado: (2020)

Oncogene addiction and immune escape: friends or foes?
por: Abdayem, Pamela, et al.
Publicado: (2020)

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
por: Pereira, Lorena, et al.
Publicado: (2013)

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
por: Attili, Ilaria, et al.
Publicado: (2018)

Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
por: Listì, Angela, et al.
Publicado: (2019)

Oncogene addiction in gliomas: Implications for molecular targeted therapy
por: Yan, Wei, et al.
Publicado: (2011)

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
por: Turkaj, Ana, et al.
Publicado: (2018)

Targeting the Vulnerabilities of Oncogene Activation
por: Huang, Christina, et al.
Publicado: (2023)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
por: Lee, Matilda, et al.
Publicado: (2018)

Pan-cancer analysis of non-oncogene addiction to DNA repair
por: Bermúdez-Guzmán, Luis
Publicado: (2021)

Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism
por: Pérez, Yolanda, et al.
Publicado: (2013)

Targeting DUBs to degrade oncogenic proteins
por: Cremer, Anjali, et al.
Publicado: (2020)

A view on EGFR-targeted therapies from the oncogene-addiction perspective
por: Perez, Rolando, et al.
Publicado: (2013)

Rhabdomyosarcomas are oncogene addicted to the activation of AVIL
por: Xie, Zhongqiu, et al.
Publicado: (2022)

Disabling an oncogenic transcription factor by targeting of control kinases
por: Vakoc, Christopher R., et al.
Publicado: (2018)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Beyond Substance Addiction: Broadening the Concept of Addiction to Include Behavioral Addiction
por: Kim, Ji Hyun, et al.
Publicado: (2013)

Regulation of tumor angiogenesis and mesenchymal–endothelial transition by p38α through TGF-β and JNK signaling
por: Batlle, Raquel, et al.
Publicado: (2019)

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
por: Doerr, Fabian, et al.
Publicado: (2017)

Oncogene alterations in non-small cell lung cancer—have we MET a new target?
por: Dempke, Wolfram C. M., et al.
Publicado: (2022)

Oncogenic addiction to high 26S proteasome level
por: Tsvetkov, Peter, et al.
Publicado: (2018)

Oncogene-like addiction to aneuploidy in human cancers
por: Girish, Vishruth, et al.
Publicado: (2023)

Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
por: Calabrese, Fiorella, et al.
Publicado: (2022)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
por: Torti, Davide, et al.
Publicado: (2011)

Internet Addiction
por: Gergely, Fehér
Publicado: (2022)

Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
por: del Barco Barrantes, Ivan, et al.
Publicado: (2017)

Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells
por: Amin, Amit Dipak, et al.
Publicado: (2015)

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
por: Putcha, Preeti, et al.
Publicado: (2015)

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
por: Ferrara, Miriam Grazia, et al.
Publicado: (2020)

Essential role of the Cdk2 activator RingoA in meiotic telomere tethering to the nuclear envelope
por: Mikolcevic, Petra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_beou0sghfle6udbb0qfp29opmc